Last Updated on January 12, 2024 by admin
Myelostat 500 Overviwe
Myelostat 500mg Capsule is used in the treatment of some kinds of cancer and to prevent painful episodes associated with sickle cell anemia. It may be also used to treat some other conditions. It is sometimes used with certain other medicines as part of combination chemotherapy.
Myelostat 500mg Capsule can be taken with or without food, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include hematological disorders, gastrointestinal symptoms, eating disorders, and weight loss. This medicine may reduce the number of blood cells in your blood thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with kidney, liver and heart function during treatment with this medicine.
Before taking it, tell your doctor if you have bleeding, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
USES OF Myelostat 500
- Ovarian cancer
- Polycythemia vera
- Chronic myeloid leukemia
- Cervical cancer
- Head and neck cancer
- Sickle cell anemia
BENEFITS OF Myelostat 500
More Information about Myelostat 500
- Myelostat 500mg Capsule should be stored at room temperature between 68°F to 77°F (20°C to 25°C).
- Keep in the original package.
- Keep away from light, moisture, and heat.
- Keep it away from children and pets.
SIDE EFFECTS OF Myelostat 500
Common side effects of Myelostat 500
- Hematological disorder
- Gastrointestinal disorder
- Eating disorder
- Azoospermia (absence of sperms)
- Decreased appetite
- Fever
- Oligospermia (low sperm count)
- Skin cancer
- Bone marrow suppression
- Hallucination
- Convulsion
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Pulmonary fibrosis
- Pulmonary edema
- Pancreatic inflammation
- Liver toxicity
- Cutaneous vasculitis
- Increased uric acid level in blood
HOW TO USE Myelostat 500
HOW Myelostat 500 WORKS
SAFETY ADVICE
Alcohol
Pregnancy
Breast feeding
Driving
Kidney
Regular monitoring of kidney function test and some blood tests may be advised while you are taking this medicine.
Liver
CHILDREN CAUTION
UNSAFE
Myelostat 500mg Capsule is not recommended for use in children and adolescents below 18 years.
Myelostat 500mg Capsule Habit Forming : NO
expert advice
All substitutes
- Take it at the same time every day, either with or without food.
- It is advisable to stay hydrated and drink plenty of fluids while taking Myelostat 500mg Capsule.
- Do not skip any dose and complete the course as suggested by your doctor.
- Use an effective method of birth control to avoid pregnancy while taking this medication.
- Your doctor may get regular blood tests done to monitor your electrolyte levels, liver function, blood cell count in your blood.
Fact Box
1. Ovarian cancer
2. Polycythemia vera
3. Chronic myeloid leukemia
4. Cervical cancer
5. Head and neck cancer
6. Sickle cell anemia
References:
- Bristol-Myers Squibb Pharmaceuticals Unlimited Company, Electronic medicines compendium (EMC), [Revised on August 2021] [ Accessed on 17 April 2023], https://www.medicines.org.uk/emc/files/pil.271.pdf
- Bristol-Myers Squibb Company, US Food and Drug Administration, [Revised on March 2016] [ Accessed on 17th April 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/016295Orig1s047,s048Lbl.pdf
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1721.
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 868.
- Rohit Kumar Agarwal et al; Hydroxyurea in Sickle Cell Disease: Drug Review; Indian Journal of Hematology & Blood Transfusion; Published on June 2014; Accessed on 17 April 2023; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022916/#__ffn_sectitle
